Literature DB >> 9858615

E2F and histone deacetylase mediate transforming growth factor beta repression of cdc25A during keratinocyte cell cycle arrest.

A Iavarone1, J Massagué.   

Abstract

cdc25A is a tyrosine phosphatase that activates G1 cyclin-dependent kinases (Cdk's). In human keratinocytes, cdc25A expression is down-regulated after the initial drop in Cdk activity caused by cell exposure to the antimitogenic cytokine transforming growth factor beta (TGF-beta) or removal of serum factors. Here we show that the TGF-beta-inhibitory-response element in the cdc25A promoter maps to an E2F site at nucleotides -62 to -55 from the transcription start site. This site is not required for basal transcription in keratinocytes. We provide evidence that the cell cycle arrest program activated by TGF-beta in human keratinocytes includes the generation of E2F4-p130 complexes that in association with histone deacetylase HDAC1 inhibit the activity of the cdc25A promoter from this repressor E2F site. This mechanism is part of a program that places keratinocytes in the quiescent state following the initial drop in Cdk activity caused by cell exposure to TGF-beta.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9858615      PMCID: PMC83949          DOI: 10.1128/MCB.19.1.916

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  47 in total

Review 1.  TGF-beta stimulation and inhibition of cell proliferation: new mechanistic insights.

Authors:  H L Moses; E Y Yang; J A Pietenpol
Journal:  Cell       Date:  1990-10-19       Impact factor: 41.582

Review 2.  The regulation of E2F by pRB-family proteins.

Authors:  N Dyson
Journal:  Genes Dev       Date:  1998-08-01       Impact factor: 11.361

3.  Growth inhibition by TGF-beta linked to suppression of retinoblastoma protein phosphorylation.

Authors:  M Laiho; J A DeCaprio; J W Ludlow; D M Livingston; J Massagué
Journal:  Cell       Date:  1990-07-13       Impact factor: 41.582

4.  TGF-beta 1 inhibition of c-myc transcription and growth in keratinocytes is abrogated by viral transforming proteins with pRB binding domains.

Authors:  J A Pietenpol; R W Stein; E Moran; P Yaciuk; R Schlegel; R M Lyons; M R Pittelkow; K Münger; P M Howley; H L Moses
Journal:  Cell       Date:  1990-06-01       Impact factor: 41.582

5.  Transforming growth factor beta and cell cycle regulation.

Authors:  M G Alexandrow; H L Moses
Journal:  Cancer Res       Date:  1995-04-01       Impact factor: 12.701

Review 6.  G1 phase progression: cycling on cue.

Authors:  C J Sherr
Journal:  Cell       Date:  1994-11-18       Impact factor: 41.582

7.  E2F-4, a new member of the E2F gene family, has oncogenic activity and associates with p107 in vivo.

Authors:  R L Beijersbergen; R M Kerkhoven; L Zhu; L Carlée; P M Voorhoeve; R Bernards
Journal:  Genes Dev       Date:  1994-11-15       Impact factor: 11.361

8.  Functional interaction between E2F-4 and p130: evidence for distinct mechanisms underlying growth suppression by different retinoblastoma protein family members.

Authors:  G Vairo; D M Livingston; D Ginsberg
Journal:  Genes Dev       Date:  1995-04-01       Impact factor: 11.361

9.  p15INK4B is a potential effector of TGF-beta-induced cell cycle arrest.

Authors:  G J Hannon; D Beach
Journal:  Nature       Date:  1994-09-15       Impact factor: 49.962

10.  Cdc25A is a novel phosphatase functioning early in the cell cycle.

Authors:  S Jinno; K Suto; A Nagata; M Igarashi; Y Kanaoka; H Nojima; H Okayama
Journal:  EMBO J       Date:  1994-04-01       Impact factor: 11.598

View more
  39 in total

1.  CDC25A phosphatase is a target of E2F and is required for efficient E2F-induced S phase.

Authors:  E Vigo; H Müller; E Prosperini; G Hateboer; P Cartwright; M C Moroni; K Helin
Journal:  Mol Cell Biol       Date:  1999-09       Impact factor: 4.272

2.  Serum-induced expression of the cdc25A gene by relief of E2F-mediated repression.

Authors:  X Chen; R Prywes
Journal:  Mol Cell Biol       Date:  1999-07       Impact factor: 4.272

3.  Isolation of a novel histone deacetylase reveals that class I and class II deacetylases promote SMRT-mediated repression.

Authors:  H Y Kao; M Downes; P Ordentlich; R M Evans
Journal:  Genes Dev       Date:  2000-01-01       Impact factor: 11.361

Review 4.  Integration of the pRB and p53 cell cycle control pathways.

Authors:  C L Stewart; A M Soria; P A Hamel
Journal:  J Neurooncol       Date:  2001-02       Impact factor: 4.130

5.  Defining the epithelial stem cell niche in skin.

Authors:  Tudorita Tumbar; Geraldine Guasch; Valentina Greco; Cedric Blanpain; William E Lowry; Michael Rendl; Elaine Fuchs
Journal:  Science       Date:  2003-12-11       Impact factor: 47.728

6.  Transforming growth factor beta facilitates beta-TrCP-mediated degradation of Cdc25A in a Smad3-dependent manner.

Authors:  Dipankar Ray; Yasuhisa Terao; Dipali Nimbalkar; Li-Hao Chu; Maddalena Donzelli; Tateki Tsutsui; Xianghong Zou; Asish K Ghosh; John Varga; Giulio F Draetta; Hiroaki Kiyokawa
Journal:  Mol Cell Biol       Date:  2005-04       Impact factor: 4.272

7.  Human papillomavirus type 16 E7 maintains elevated levels of the cdc25A tyrosine phosphatase during deregulation of cell cycle arrest.

Authors:  Don X Nguyen; Thomas F Westbrook; Dennis J McCance
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

8.  The microRNA 424/503 cluster reduces CDC25A expression during cell cycle arrest imposed by transforming growth factor β in mammary epithelial cells.

Authors:  David Llobet-Navas; Ruth Rodriguez-Barrueco; Janis de la Iglesia-Vicente; Mireia Olivan; Veronica Castro; Laura Saucedo-Cuevas; Netonia Marshall; Preeti Putcha; Mireia Castillo-Martin; Evan Bardot; Elena Ezhkova; Antonio Iavarone; Carlos Cordon-Cardo; Jose M Silva
Journal:  Mol Cell Biol       Date:  2014-09-29       Impact factor: 4.272

9.  Phosphorylation-dependent and -independent functions of p130 cooperate to evoke a sustained G1 block.

Authors:  K Hansen; T Farkas; J Lukas; K Holm; L Rönnstrand; J Bartek
Journal:  EMBO J       Date:  2001-02-01       Impact factor: 11.598

Review 10.  In vivo roles of CDC25 phosphatases: biological insight into the anti-cancer therapeutic targets.

Authors:  Hiroaki Kiyokawa; Dipankar Ray
Journal:  Anticancer Agents Med Chem       Date:  2008-12       Impact factor: 2.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.